BARD TEGRESS TRANSURETHRAL STAINLESS INJECTION NEEDLE 653300

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 07 report with the FDA on 2006-08-23 for BARD TEGRESS TRANSURETHRAL STAINLESS INJECTION NEEDLE 653300 manufactured by C.r. Bard, Inc..

Event Text Entries

[526796] It was reported that when the doctor was performing a urethral implant procedure on a male patient who had a lot scar tissue and upon attempting the third injection, he was unable to inject the bulking material. The dr advanced the injection needle further in order to get past the scar tissue, and he was then able to inject the material. Under fluoroscopy, the doctor noted that the tip of the injection needle was missing. He removed the remainder of the needle from the patient and observed that approximately 2mm of the needle tip was missing. He detached the needle from the syringe and the nurse discarded it. The nurse opened another needle to use in order to complete the procedure. The doctor believes that the tip of the needle remains within the bulk of the implanted material inside of the patient. He is not going to remove it at this time. No further complications have been reported.
Patient Sequence No: 1, Text Type: D, B5


[7795988] No sample was returned for evaluation. A review of the device history record (dhr) found nothing to indicate this type of problem. The product met all required specifications. A review of component dhr determined that all needle measurements: needle tip id and tubing id, tip length, needle od were certified by the supplier as within specification. Visual inspection by iqc determined 80 units were inspected under 2x - 3x magnification and passed inspection with no defects noted. A review of the complaint history showed no other events of this type having been reported for this product. While no exact conclusions can be made without a sample to evaluate, it is believed that the needle tip may have become damaged when trying to penetrate the scar tissue on the third attempt to injecting the implant material.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1018233-2006-00144
MDR Report Key770769
Report Source07
Date Received2006-08-23
Date of Report2006-08-23
Date Mfgr Received2006-07-25
Device Manufacturer Date2006-01-01
Date Added to Maude2006-10-20
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactVIVIAN STEPHENS
Manufacturer Street8195 INDUSTRIAL BLVD.
Manufacturer CityCOVINGTON GA 30014
Manufacturer CountryUS
Manufacturer Postal30014
Manufacturer Phone7707846902
Manufacturer G1C.R. BARD, INC.
Manufacturer Street8195 INDUSTRIAL BLVD.
Manufacturer CityCOVINGTON GA 30014
Manufacturer CountryUS
Manufacturer Postal Code30014
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameBARD TEGRESS TRANSURETHRAL STAINLESS INJECTION NEEDLE
Generic NameTEGRESS TRANSURETHRAL INJECTION NEEDLE
Product CodeLMI
Date Received2006-08-23
Model NumberNA
Catalog Number653300
Lot NumberCVQA0018
ID NumberNA
Device Expiration Date2008-01-01
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Age6 MO
Device Eval'ed by MfgrR
Implant FlagY
Date RemovedA
Device Sequence No1
Device Event Key758570
ManufacturerC.R. BARD, INC.
Manufacturer Address8195 INDUSTRIAL BLVD. COVINGTON GA 30014 US
Baseline Brand NameBARD TEGRESS TRANSURETHRAL STAINLESS INJECTION NEEDLE
Baseline Generic NameTEGRESS TRANSURETHRAL INJECTION NEEDLE
Baseline Model NoNA
Baseline Catalog No653300
Baseline IDNA


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2006-08-23

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.